Results 61 to 70 of about 1,288 (163)
Introduction Nasal chondromesenchymal hamartoma (NCMH) is a rare cause of nasal mass in infants and children. It was first described in 1998, and since then, only 63 previous cases have been reported. Case Report Here, we report a case of a 4‐day‐old neonate with a right‐sided nasal mass presenting with respiratory distress since birth.
Mikiyas Olani +6 more
wiley +1 more source
Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report
Malignant tumors of the nasal cavity are rare. We report the case of a 48 years old man who consulted us with a 2-year history of progressive nasal obstruction, occasional epistaxis, facial pain, and watering of the eyes.
Husain Nuzhat, Gupta Seema, Sundar Sham
doaj +1 more source
ABSTRACT Objectives To evaluate the impact of the extent of resection and adjuvant radiotherapy (RT) on treatment outcomes in patients with early‐stage olfactory neuroblastoma (ONB) without definite dural invasion. Methods A retrospective review of ONB cases from two centers within a single institution between 1992 and 2023 was performed ...
Tae‐Bin Won +8 more
wiley +1 more source
International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 646-649, June 2026.
Vidit M. Talati +11 more
wiley +1 more source
S S, Nair, M I, Elizabeth
openaire +3 more sources
Treatment Outcomes of Olfactory Neuroblastoma: A Multicenter Study by the Korean Sinonasal Tumor and Skull Base Surgery Study Group [PDF]
Objectives. Due to the rarity of olfactory neuroblastoma (ONB), there is ongoing debate about optimal treatment strategies, especially for early-stage or locally advanced cases.
Sang Duk Hong +11 more
doaj +1 more source
Hyams Grade and Ki‐67 as Predictive Factors for Primary Treatment Failure in Olfactory Neuroblastoma
The aim of the present study was to investigate the influence of various prognostic parameters on the occurrence of primary tumor progression and/or tumor recurrence (TPR) in esthesioneuroblastoma after primary curative therapy in a single center. Time to first TPR in esthesioneuroblastoma was significantly shorter in cases with a younger age and ...
Michael Koch +5 more
wiley +1 more source
Upright proton therapy for esthesioneuroblastoma: a single-institution experience
AimThis study presents an analysis (efficacy and toxicity) of outcomes in patients with esthesioneuroblastoma after pencil beam proton therapy with a fixed beamline in the upright position.BackgroundEsthesioneuroblastoma (ENB) is an extremely rare tumor ...
Konstantin Gordon +14 more
doaj +1 more source
Health Disparities in Rhinology—A Scoping Review
Abstract Objective This scoping review aims to systematically evaluate the existing health disparities research in rhinology, identifying key themes, gaps, and opportunities for future investigation. Data Sources A systematic search of PubMed, Embase, and Web of Science was conducted using terms related to rhinology topics and health disparities as ...
Jaynelle Gao +6 more
wiley +1 more source
Esthesioneuroblastoma (ENB) is a rare tumor derived from olfactory neuroepithelium. ENB in a site outside of where olfactory epithelium exists is exceedingly rare with only five cases of ENB isolated to the sphenoid sinuses described in the literature to
Josephine Akinfolarin +6 more
doaj +1 more source

